Caffeine and Less Invasive Surfactant Administration for Respiratory Distress Syndrome of the Newborn.

NEJM evidence2023Katheria A, Ines F, Banerji A, et al.

Study designOther primary literature

SubjectHuman

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

CaffeineHumansInfant, NewbornInfant, PrematureLipoproteinsPulmonary SurfactantsRespiratory Distress Syndrome, NewbornSurface-Active Agents

DOI 10.1056/evidoa2300183

PMID 38320499